← Back to all trials
Not Yet Recruiting
NCT05710900
DiEt ChoIce to Promote Type 2 Diabetes rEmission
Conditions: Type 2 Diabetes
Sex: All
Ages: 20 Years – 80 Years
Phase: NA
Enrollment: 100
Sponsor: University of British Columbia
Summary
Type 2 diabetes is typically viewed as a chronic, progressive, and lifelong condition.
Patients and their healthcare providers "manage" type 2 diabetes through lifestyle modifications and various types of medications designed to lower blood sugar.Exciting new research indicates that "remission" of type 2 diabetes - defined as returning blood sugar into the normal range without having to use medications - through therapeutic nutrition may be possible for many people living with the condition.We will examine the preference, adherence and clinical results of a low-calorie diet or low-carbohydrate diet in type 2 diabetes remission rates.
Eligibility Criteria
Inclusion Criteria:Aged 20-80 years oldDiagnosed with T2D by a physician,HbA1c ≥ 6.0% using at least one glucose-lowering medication,Body Mass Index ≥27 kg/m2 andNo contraindications or dietary restrictions to following a low-carbohydrate/low-calorie diet.Exclusion Criteria:History of heart disease, heart attack, heart failure, stroke or coronary artery disease within the previous 2 years,any current unstable cardiovascular disorder,history of liver disease,history of kidney disease with eGFR <30 mls/min/1.73
m2,history of neurological disease,previous bariatric surgery,weight loss (≥5%) within the last six monthscurrently pregnant or lactating, or planning on becoming pregnant within the next 12 months,history of cancer within the previous 5 years,dietary restrictions or allergies that would inhibit adherence to the intervention diet,history of eating disorders,moderate or severe depression, anxiety or mental health condition that impacts daily life,currently following a low-carbohydrate or low-calorie diet, andunable to access the Internet (for communication with research team and RD).
Source: ClinicalTrials.gov (NCT05710900). StuddyBuddy aggregates publicly available trial information.